Biogenesis aberration: One of the mechanisms of thrombocytopenia in COVID-19
Open Access
- 20 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14, 1100997
- https://doi.org/10.3389/fphys.2023.1100997
Abstract
Background: The pathogenesis of COVID-19, including thrombocytopenia, has not been fully clarified. The lungs are a major organ of platelet production and thrombocytopenia induced by severe COVID-19 was proposed. Methods: the change of platelet level was analysed with clinical parameters in 95 hospitalized COVID-19 patients in Wuhan Third Hospital. The production of platelets in the lungs was explored in an ARDS rat model. Results: The level of platelets was negatively correlated with disease severity and was recovered with disease improvement. The non-survivors were accompanied by lower levels of platelet. The odds ratio (OR) of the valley level of the platelet count (PLTlow) was greater than 1, suggesting that PLTlow could be a death exposure factor. The platelet/lymphocyte ratio (PLR) was positively associated with severity of COVID-19, and the PLR threshold of 248.5 was best correlated with death risk (sensitivity 0.641 and specificity 0.815). To demonstrate the possible biogenesis aberration of platelet in lungs, an LPS-induced ARDS rat model was applied. Lower level of platelet in peripheral and less production of platelet from lungs in ARDS were demonstrated. Though megakaryocyte (MK) number in ARDS lungs is higher than controls, the immature platelet fraction (IPF) in postpulmonary blood is still at the same level as prepulmonary in ARDS rat, indicating that ARDS rats generated fewer platelets in lungs. Conclusion: Our data suggested that COVID-19-induced severe lung inflammation may impair platelet production in the lung. Thrombocytopenia may be mainly caused by platelet consumption for multiorgan thrombosis; however, biogenesis aberration of platelet in the lung induced by diffuse interstitial pulmonary damage cannot be ruled out.This publication has 58 references indexed in Scilit:
- Therapeutic Effect of Intravenous Infusion of Perfluorocarbon Emulsion on LPS-Induced Acute Lung Injury in RatsPLOS ONE, 2014
- Platelet–lymphocyte cross-talkJournal of Leukocyte Biology, 2008
- Megakaryocytes and platelet homeostasis in diffuse alveolar damageExperimental and Molecular Pathology, 2007
- Lung damage may induce thrombocytopeniaPlatelets, 2006
- Thrombocytopenia in patients with severe acute respiratory syndrome (review)Hematology, 2005
- Effects of Oxygen-Induced Lung Damage on Megakaryocytopoiesis and Platelet Homeostasis in a Rat ModelPediatric Research, 2003
- Clinical presentations and outcome of severe acute respiratory syndrome in childrenThe Lancet, 2003
- Platelet survival time in patients with hypoxemia and pulmonary hypertension.Journal of the American College of Cardiology, 1977
- Megakaryocytes and Platelets in Central Venous and Arterial BloodActa Haematologica, 1969
- THE PRODUCTION OF BLOOD PLATELETS IN THE LUNGSThe Journal of Experimental Medicine, 1937